BACKGROUND: Staphylococcus aureus has a notable ability to acquire resistance to antibiotics, and methicillin resistance represents a growing public health problem. Methicillin-resistant S. aureus (MRSA) has also become important outside the hospital environment, particularly in the United States. In Brazil, since 2005, cases of community skin infections caused by MRSA have been reported, but resistance studies involving outpatients are scarce. OBJECTIVE: To know the resistance profile of S. aureus involved in skin and soft tissue infections of patients seen at the Dermatology outpatient clinic of a university hospital in Recife, Pernambuco State, northeastern Brazil. METHODS: Prospective study involving 30 patients with skin and soft tissue infections, seen at the Dermatology outpatient clinic from May until November 2011. To evaluate the susceptibility of S. aureus to antibiotics, the disk diffusion method and oxacillin screening agar were used. RESULTS: From a total of 30 samples of skin lesions, 19 (63%) had positive culture for S. aureus. The following resistance patterns of S. aureus were observed: penicillin, 95%; tetracycline, 32%; erythromycin, 21%; gentamicin, 16%; cefoxitin, 11%; oxacillin, 11%; trimethoprim-sulfamethoxazole, 11%; chloramphenicol, 11%; clindamycin, 5% ; and ciprofloxacin, 0%. One of the identified MRSA was obtained from a patient without risk factors for its acquisition, and was resistant, beyond to the beta-lactams, only to tetracycline. CONCLUSIONS: With regard to the resistance patterns of S. aureus, resistances to tetracycline, erythromycin and gentamicin were the highest. It was documented, for the first time in Pernambuco, a case of skin infection caused by community-associated MRSA.
BACKGROUND:Staphylococcus aureus has a notable ability to acquire resistance to antibiotics, and methicillin resistance represents a growing public health problem. Methicillin-resistant S. aureus (MRSA) has also become important outside the hospital environment, particularly in the United States. In Brazil, since 2005, cases of community skin infections caused by MRSA have been reported, but resistance studies involving outpatients are scarce. OBJECTIVE: To know the resistance profile of S. aureus involved in skin and soft tissue infections of patients seen at the Dermatology outpatient clinic of a university hospital in Recife, Pernambuco State, northeastern Brazil. METHODS: Prospective study involving 30 patients with skin and soft tissue infections, seen at the Dermatology outpatient clinic from May until November 2011. To evaluate the susceptibility of S. aureus to antibiotics, the disk diffusion method and oxacillin screening agar were used. RESULTS: From a total of 30 samples of skin lesions, 19 (63%) had positive culture for S. aureus. The following resistance patterns of S. aureus were observed: penicillin, 95%; tetracycline, 32%; erythromycin, 21%; gentamicin, 16%; cefoxitin, 11%; oxacillin, 11%; trimethoprim-sulfamethoxazole, 11%; chloramphenicol, 11%; clindamycin, 5% ; and ciprofloxacin, 0%. One of the identified MRSA was obtained from a patient without risk factors for its acquisition, and was resistant, beyond to the beta-lactams, only to tetracycline. CONCLUSIONS: With regard to the resistance patterns of S. aureus, resistances to tetracycline, erythromycin and gentamicin were the highest. It was documented, for the first time in Pernambuco, a case of skin infection caused by community-associated MRSA.
Authors: O P de Miranda; M C Silva-Carvalho; A Ribeiro; F Portela; R P Cordeiro; N Caetano; C F L Vidal; A M S Figueiredo Journal: Clin Microbiol Infect Date: 2007-10-23 Impact factor: 8.067
Authors: Gregory J Moran; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; David A Talan Journal: N Engl J Med Date: 2006-08-17 Impact factor: 91.245
Authors: Nicolas A Forcade; Michael L Parchman; James H Jorgensen; Liem C Du; Natalie R Nyren; Lucina B Treviño; Joel Peña; Michael W Mann; Abilio Muñoz; Sylvia B Treviño; Eric M Mortensen; Brian L Wickes; Brad H Pollock; Christopher R Frei Journal: J Am Board Fam Med Date: 2011 Sep-Oct Impact factor: 2.657
Authors: Silvana M M Cavalcanti; Emmanuel R de França; Carlos Cabral; Marinalda A Vilela; Francisco Montenegro; Daniela Menezes; Angela C R Medeiros Journal: Braz J Infect Dis Date: 2005-06-06 Impact factor: 1.949
Authors: Binh An Diep; Henry F Chambers; Christopher J Graber; John D Szumowski; Loren G Miller; Linda L Han; Jason H Chen; Felice Lin; Jessica Lin; Tiffany HaiVan Phan; Heather A Carleton; Linda K McDougal; Fred C Tenover; Daniel E Cohen; Kenneth H Mayer; George F Sensabaugh; Françoise Perdreau-Remington Journal: Ann Intern Med Date: 2008-01-30 Impact factor: 25.391
Authors: Cristiana M Nascimento-Carvalho; Ticiana G Lyra; Noraney N Alves; Renilza M Caldas; Maria Goreth Barberino Journal: Microb Drug Resist Date: 2008-06 Impact factor: 3.431
Authors: John M Boyce; Barry Cookson; Keryn Christiansen; Satoshi Hori; Jaana Vuopio-Varkila; Sesin Kocagöz; A Yasemin Oztop; Christina M J E Vandenbroucke-Grauls; Stephan Harbarth; Didier Pittet Journal: Lancet Infect Dis Date: 2005-10 Impact factor: 25.071
Authors: Monica Bortolin; Alessandro Bidossi; Elena De Vecchi; Maura Avveniente; Lorenzo Drago Journal: Front Microbiol Date: 2017-06-08 Impact factor: 5.640
Authors: Luciane Cristina Gelatti; Renan Rangel Bonamigo; Ana Paula Becker; Letícia Maria Eidt; Letícia Ganassini; Pedro Alves d' Azevedo Journal: An Bras Dermatol Date: 2014 May-Jun Impact factor: 1.896